Michael Andreas Ermer

Dr. Michael Andreas Ermer


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
MEMichael Andreas Ermer
Michael Andreas Ermer
KKK. Kirsch
K. Kirsch
GBG. Bittermann
G. Bittermann
TFTobias Fretwurst
Tobias Fretwurst
KVK. Vach
K. Vach
MMMarc Metzger
Marc Metzger

1 September 2015 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
PTP. Thönissen
P. Thönissen
MEMichael Andreas Ermer
Michael Andreas Ermer
RSR. Schmelzeisen
R. Schmelzeisen
RGR. Gutwald
R. Gutwald
MMM.C. Metzger
M.C. Metzger
GBG. Bittermann
G. Bittermann

1 March 2018 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
MEMichael Andreas Ermer
Michael Andreas Ermer
SKSimon C. Kottmann
Simon C. Kottmann
JOJörg-Elard Otten
Jörg-Elard Otten
AWAnnette Wittmer
Annette Wittmer
PPPhilipp Poxleitner
Philipp Poxleitner
KPKlaus Pelz
Klaus Pelz

1 April 2013 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
MEMichael Andreas Ermer
Michael Andreas Ermer
RGRalf Gutwald
Ralf Gutwald
MSMartin Schumacher
Martin Schumacher
RSRainer Schmelzeisen
Rainer Schmelzeisen
CTChristian Taschner
Christian Taschner

27 December 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
PPPhilipp Poxleitner
Philipp Poxleitner
MEMichael Andreas Ermer
Michael Andreas Ermer
RTRainer Trittler
Rainer Trittler
CFCarolin Lena Feuerstein
Carolin Lena Feuerstein
JOJörg-Elard Otten
Jörg-Elard Otten
DSDavid Steybe
David Steybe
The aim of this study was to evaluate the concentration of penicillin G in bone affected by antiresorptive agent-related osteonecrosis of the jaw (ARONJ) following a single preoperative dose of 10 million international units (6000 mg). ARONJ is a major concern in patients administered antiresorptive agents for conditions associated with pathologically increased bone resorption. Antibiotic therapy is a key component of most treatment approaches for ARONJ and penicillin based regimens, providing a cost effective therapy option with a favorable side effect profile, are administered most frequently. In this study, high performance liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) was applied to evaluate penicillin G concentration in serum and bone samples of 19 patients suffering from ARONJ and undergoing surgical treatment under perioperative intravenous (IV) antibiotic therapy. Penicillin G bone concentrations were above the limit of detection (0.1 μg/g bone tissue) in 16 out of 19 samples, with a median concentration of 2.7 μg/g (range 0.1–8.8 μg/g). Penicillin G concentrations in intraoperative serum samples were above the limit of detection in all serum samples, with a median concentration of 116 μg/mL (range 1–232 μg/mL). Thus, considering bacteria frequently found in ARONJ lesions, penicillin G at levels providing adequate antimicrobial activity was detected in the serum and 16 out of 19 osteonecrotic lesions of patients suffering from ARONJ.

28 December 2021 in Cancers
Verified
Journal Article
Open access
PDF file
LBLeonard Simon Brandenburg
Leonard Simon Brandenburg
MMMarc Metzger
Marc Metzger
PPPhilipp Poxleitner
Philipp Poxleitner
PVPit Jacob Voss
Pit Jacob Voss
Kirstin VachKirstin Vach
Kirstin Vach
MEMichael Andreas Ermer
Michael Andreas Ermer
There is no consensus on the effect of red blood cell (RBC) transfusions on patients with oral squamous cell carcinoma (OSCC). The aim of this study was to investigate the association between RBC administration and the occurrence of distant metastases (M+) after surgical treatment of OSCC. All medical records of patients who underwent primary surgery for OSCC in our department (2003–2019) were analyzed retrospectively (n = 609). Chi and Cox regression models were used to analyze the influence of transfusion on the development of M+, and survival rates. Kaplan–Meier curves were used for graphical presentation. A multitude of patient-specific factors showed a statistical impact in univariate analysis (transfusion, age, gender, diabetes, pT, pN, L, V, Pn, G, UICC, adjuvant therapy, free microvascular transplant, preoperative hemoglobin level). Transfusion status and pN stage were the only variables that showed a significant correlation to M+ in the multivariate Cox model. The hazard ratios for the occurrence of M+ were 2.42 for RBC transfusions and 2.99 for pN+. Administration of RBC transfusions was identified as a significant prognostic parameter for the occurrence of distant metastases after surgical treatment of OSCC. Hence, the administration of RBC transfusions should be considered carefully in the perioperative management.